Diabetic Neuropathy
A research study looking for people to help test a new pain medication called Suzetrigine to help with neuropathy pain in the feet and legs.
18–80
About 19 weeks (approximately 4 months)
Up to $3000+
About This Study
This study is testing whether a medication called Suzetrigine (SUZ) can help reduce pain caused by diabetic peripheral neuropathy (DPN). DPN can cause burning, tingling, and pain in the feet and legs. Researchers want to find out if SUZ works better than a placebo (inactive pill) and how it compares to pregabalin, a medication already approved for this type of pain.
If you join, you will be placed by chance into one of three groups: SUZ, pregabalin, or placebo. Neither you nor your study doctor will know which group you are in. You will take one tablet every morning and one capsule three times a day for 12 weeks. You will also use an electronic diary each day to record your pain level. Study visits will take place at the clinic, and your health will be closely monitored throughout.
Your participation is completely voluntary. You can leave the study at any time. All study-related tests, procedures, and study medications are provided at no cost to you. You may also be paid and reimbursed for travel and meals for your time and participation.
You May Qualify If You
- You are between 18 and 80 years old
- You have been diagnosed with type 1 or type 2 diabetes
- You have had pain in both feet or legs due to diabetic nerve damage for at least 1 year
- Your blood sugar (HbA1c) level is 9% or below
- Your pain is moderate to severe on a standard 0–10 pain scale
- You have not previously used Suzetrigine (SUZ), VX-993, or Journavx™
- You are willing to stop other pain medications (except acetaminophen/Tylenol) for at least 14 days before starting the study
Interested in This Study?
Contact us to learn more and see if you qualify.